Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2015.476 | Hope in the Context of Chronic Musculoskeletal Pain: Relationships of Hope to Pain and Psychological Distress |
Dr. OR Yin Ling 柯燕玲 |
| 2014.366 | A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy | Dr OZAKI Risa |
| 2014.450 | A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin® (pyridoxamine dihydrochloride) in Subjects with Nephropathy Due to Type 2 Diabetes (PIONEER) | Dr. OZAKI Risa |
| 2015.351 | An open-label, randomized, multi-center, single dose, two-period, two-sequence crossover study to investigate the bioequivalence of Peginterferon (PEG-IFN) alfa-2a benzyl alcohol-free formulation versus the reference market formulation following subcutaneous administration via prefilled syringe in healthy Chinese subjects |
Dr. OZAKI Risa Not applicable |
| 2015.195 | Insulin, Glucagon and Incretin Response to 75g Glucose Tolerance Tests: Comparison of Type 2 diabetes and healthy control among Asian Countries |
Dr. OZAKI Risa 尾崎麗莎 |
| 2015.095 | A long term, randomised, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus Harmony Outcomes Trial | Dr. OZAKI Risa |
| 2014.425 | A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy - SONAR: Study Of Diabetic Nephropathy with Atrasentan | Dr. OZAKI Risa |
| 2010.588 | The correlation between increased arterial stiffness and the 5-year probability of major clinical event generated from the risk engine JADE program | Dr. Ozaki Risa |
| 2012.134 | A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-DAILY ADMINISTRATION OF A PHOSPHODIESTERASE 5 INHIBITOR (PF-00489791) IN ADULTS WITH TYPE 2 DIABETES AND OVERT NEPHROPATHY | Dr Ozaki Risa |
| 2008.322 | Combination Therapy of Insulin Glargine and Sitagliptin in Patients with Type 2 Diabetes Not Adequately Controlled by A Previous Treatment with Metformin and Either Insulin Glargine or Sitagliptin (EASIE Extension trial | Dr Ozaki Risa |
| 2012.329 | A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Glimepiride When Used in Combination with Metformin in Subjects with Type 2 Diabetes | Dr. OZAKI Risa |
| 2012.480 | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus | Dr. OZAKI Risa |
| 2011.029 | A Randomized, Double-Blind, Placebo-controlled, 3-Arm, Parallel-Group, 26-Week, Multicenter Study With a 26-Week Extension, to Evaluate the Efficacy, Safety and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment | Dr. Ozaki Risa |
| 2008.321 | Superiority Study of Insulin Glargine Over Sitagliptin in Insulin-Na_ve Patients with Type 2 Diabetes Treated With Metformin and Not Adequately Controlled (EASIE Trial | Dr Ozaki Risa |
| 2012.486 | Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High-Risk for Vascular Outcomes - the ACCELERATE Study | Dr. OZAKI Risa |
| 2009.428 | Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study | Dr Ozaki Risa |
| 2011.080 | A Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing the Efficacy and Safety of a Sitagliptin-Based Treatment Paradigm to a Liraglutide-Based Treatment Paradigm in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Monotherapy | Dr Ozaki Risa |
| 2014.010 | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 26-WEEK MULTICENTER STUDY WITH A 78-WEEK EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF ERTUGLIFLOZIN IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND INADEQUATE GLYCEMIC CONTROL ON METFORMIN MONOTHERAPY | Dr. OZAKI Risa |
| 2009.109 | A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination with Metformin Compared with Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects with Type 2 Diabetes Mellitus | Dr Ozaki Risa |
| 2013.531 | A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-DAILY ADMINISTRATION OF A CHEMOKINE CCR2/5 RECEPTOR ANTAGONIST (PF-04634817) IN ADULTS WITH TYPE 2 DIABETES AND OVERT NEPHROPATHY | Dr Ozaki Risa |
| 2008.041 | A Phase II, Double-blind, Placebo-controlled, Dose-finding Study in Patients with Diabetic Neuropathic Pain to Evaluate Efficacy and Safety of TAK-583 | Dr Ozaki Risa |
| 2013.490 | A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog, LY2963016, to Lantus® in Combination with Mealtime Insulin Lispro in Adult Patients with Type 1 Diabetes Mellitus: The ELEMENT 3 Study | Dr. Ozaki Risa |
| 2012.273 | A Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia | Dr Ozaki Risa |
| 2011.152 | A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus | Dr. OZAKI Risa |
| 2011.604 | A 5-year study to compare the durability of glycemic control of a combination regimen with vildagliptin & metformin versus standard-of-care monotherapy with metformin, initiated in treatment-naïve patients with type 2 diabetes mellitus | Dr. OZAKI Risa |
| 2013.098 | A Multicenter Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr Ozaki Risa |
| 2013.152 | A randomized controlled trial of a tailored intervention targeted smoking type 2 diabetic patients to promote smoking cessation and improve glycamic control | Dr. Ozaki Risa |
| 2010.138 | A Phase III, Randomized, Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on a Sulfonylurea in Combination With Metformin | Dr. Ozaki Risa |
| 2010.344 | A phase III randomised, double-blind, active-controlled parallel group efficacy and safety study of BI 10773 compared to glimepiride administered orally during 104 weeks with a 104-week extension period in patients with type 2 diabetes mellitus and insufficient glycaemic control despite metformin treatment | Dr. OZAKI Risa |
| 2013.293 | A randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of different oral doses of BAY 94-8862 in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic nephropathy | Dr. OZAKI Risa |
| 2012.108 | A Phase III, multicentre, international, randomised, parallel group, double blind cardiovascular safety study of BI 10773 (10 mg and 25 mg administered orally once daily) compared to usual care in type 2 diabetes mellitus patients with increased cardiovascular risk | Dr. OZAKI Risa |
| 2014.136 | Verifying Insulin Strategy and Initial Health Outcome Analysis (VISION) | Dr. OZAKI Risa |
| 2018.590 | The effectiveness of the NET-CQI program in improving Nurses' Work Environment | Ms. PAGUIO Jenniffer |
| 2014.218 | Comparison on 3D Morphology of Webspace and Outcomes of Syndactyly Surgical Treatment | Dr Pak Cheong Ho |
| 2008.035 | Generalised Joint Laxity in Local Athletes with Unilateral Anterior Cruciate Ligament Injury | Physiotherapist Pak Chun Han |
| 2021.614 | The impact of an external breast prosthesis on the postural balance and gait parameters of post-mastectomy women | Ms. PAK Lok Yee |
| 2009.629 | Design of a school-based adapted physical activity program for children with physical disability after the 2007 Sichuan Earthquake | Miss Pak Pui Man |
| 2008.165 | The Comparison of Tolerance Between Contact Rhinoscopy and Conventional Nasendoscopy in Non-Irradiated and Irradiated Patients | Dr Pak Wai, Martin |
| 2013.376 | Relationship between Attitude and Drug Adherence among Type II Diabetic Patients in Primary Setting: A Quantitative Study | Miss PAN MALIRA |
| 2005.031 | Identification of Genes for Primary Open Angle Glaucoma | Prof. PANG Calvin Chi Pui |
| 2012.100 | Characterization of the high myopia gene in the MYP20 locus | Prof. PANG Chi Pui |
| 2013.049 | Characterization of a novel disease gene for normal tension glaucoma and identification of new genetic loci | Prof. PANG Chi Pui |
| 2004.203 | Genetic Anaylsis for Eye Diseases | Prof. PANG Chi Pui |
| 2009.162 | Proteomic Analysis of Aqueous and Vitreous Samples from Patients with Age-Related Macular Degeneration | Prof. PANG Chi Pui |
| 2016.734 | Genetic Biomarkers for Longitudinal Glaucoma Progression |
Prof. PANG Chi Pui 彭智培 |
| 2014.629 | Primary open angle glaucoma-associated ABCA1-APOE pathway in retinal ganglion cell protection | Prof. PANG Chi Pui |
| 2023.533 | Taxonomic and functional profiling of healthy ocular surface microbiome in Hong Kong children | Prof. PANG Chi Pui |
| 2007.224 | Genetic Studies and the Correlation between Clinical and Genetic Findings in Patients withi Retinal Diseases of Polypoidal Choroidal Vasculopathy (PCV) and Age-related Macular Degeneration (AMD) | Prof. PANG Chi Pui |
| 2001.201 | A Study on Genetic Expressions during Ocular Development in Human Molecular Embryogenesis | Prof. PANG Chi Pui |
| 2016.402 | Physiotherapy evaluation of neck functions after decompression of the cervical spine for people with multilevel cervical spondylosis |
Mr. PANG Chun Yiu 彭俊耀 |
Page 180 of 254.